Neurocrine Biosciences Inc vs Star Bulk Carriers Corp — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Star Bulk Carriers Corp trades at $26.63 (market cap $2.91B). The key difference: Neurocrine Biosciences Inc is far larger — about 6× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 3.95% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | SBLK | |
|---|---|---|
Market Cap | $17.40B | $2.91B |
Sector | Health | Industrials |
52-Week High | $180.55 | $28.21 |
52-Week Low | $123.10 | $16.79 |
Enterprise Value | $16.49B | $3.61B |
Dividend Yield | — | 3.95% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →